Physician profile
Daniel Michael Sciubba
NPI 1043357270
$788,779.77
in general payments reported to CMS, 2019-2025
24 companies · $241K in 2025
The $241K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85K · 2020: $64K · 2021: $87K · 2022: $131K · 2023: $83K · 2024: $96K · 2025: $241K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $278K · Royalty Or License: $68K · Travel and Lodging: $31K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Food and Beverage: $10K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000 · Education: $16.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $278,448.75 |
| Royalty Or License | $67,970.34 |
| Travel and Lodging | $31,294.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,750.00 |
| Food and Beverage | $10,383.42 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
| Education | $16.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $166,966.36 | 2019-2025 | Trialtis, Confidence Spinal Cement System, Symphony |
| Baxter Healthcare | $139,471.56 | 2019-2025 | Tisseel, Floseal |
| Medical Device Business Services, INC. | $137,019.76 | 2019-2025 | Conduit, Symphony, Confidence Spinal Cement System |
| Stryker Corporation | $99,727.34 | 2019-2025 | Sonopet Iq, Core |
| Medtronic, INC. | $64,663.92 | 2021-2025 | Unid_pass, Cd Horizon Spinal System, Catalyft Pl Expandable Interbody System |
| Pacira Pharmaceuticals Incorporated | $47,678.68 | 2022-2025 | Exparel, Iovera, Zilretta |
| Icotec Medical INC. | $40,882.16 | 2024-2025 | Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm |
| Augmedics INC. | $28,742.91 | 2020-2024 | Xvision |
| Medtronic USA, INC. | $18,507.48 | 2019-2020 | |
| Si-Bone, INC. | $16,725.03 | 2022-2025 | |
| Synthes Gmbh | $9,150.79 | 2019-2024 | |
| Nuvasive, INC. | $5,782.30 | 2019-2023 | Xlif, Pulse |
| Ethicon INC. | $5,400.00 | 2021-2024 | |
| Highridge Medical LLC | $4,095.00 | 2025 | Spine-None |
| Depuy Synthes Sales INC. | $1,894.41 | 2019-2025 | Trialtis, Teligen, Expedium |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $1,357.09 | 2024-2025 | Other - Miscellaneous |
| Globus Medical, INC. | $234.40 | 2024 | Direct Look |
| Carlsmed, INC. | $188.05 | 2024 | Aprevo |
| Biocomposites INC | $77.76 | 2024-2025 | Stimulan |
| Vb Spine LLC | $64.26 | 2025 | Nile Alternative Fixation System, Cascadia Interbody System, Yukon Oct Spinal System |
| Zap Surgical Systems, INC. | $57.04 | 2023 | Zap-X Mv Imager, Zap-X Radiosurgery System, Zap-X Treatment Planning Software |
| Bioventus LLC | $43.53 | 2023 | Bonescalpel |
| 4web, INC. | $32.16 | 2023 | Spine Truss System |
| Zimmer Biomet Holdings, INC. | $17.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sciubba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.